Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast

<div>The Stock Day Podcast welcomed Enzolytics, Inc. (ENZC) (“the Company”), a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases. Director and COO of the Company, Dr. Gaurav Chandra, joined Stock Day host Everett Jolly</div>